Blog
RSS FeedPosted by Michael Wonder on 29 Apr 2021
Integration of ethical considerations into HTA reports: an analysis of integration levels using a systematic review
26 April 2021 - The objective was to describe the type and level of ethical integration in published health technology assessment ...
Posted by Michael Wonder on 24 Mar 2021
Biden’s choice and FDA’s loosening standards of evidence
23 March 2021 - The US Food and Drug Administration is widely considered the world’s premier regulator of drugs and devices, ...
Posted by Michael Wonder on 01 Nov 2020
The FDA’s Digital Health Center Of Excellence: why it matters and what it means to you
29 October 2020 - Last month, the US FDA launched the Digital Health Center of Excellence, bolstering the shift toward digital ...
Posted by Michael Wonder on 26 Oct 2020
European Union would apply lower threshold in assessing COVID-19 vaccine
25 October 2020 - The EU’s drug regulator is willing to approve a vaccine even if it were effective in less ...
Posted by Michael Wonder on 30 Sep 2020
The FDA and the importance of trust
30 September 2020 - As SARS-CoV-2 emerged, the global scientific community first studied the virus at the bench, then took what ...
Posted by Michael Wonder on 08 Sep 2020
Biopharma leaders unite to stand with science
8 September 2020 - Nine CEOs sign historic pledge to continue to make the safety and well-being of vaccinated individuals the ...
Posted by Michael Wonder on 11 Aug 2020
FDA head pledges 'we will not cut corners' on coronavirus vaccine
10 August 2020 - The head of the FDA pledged Monday that the U.S. "will not cut corners" in its ...
Posted by Michael Wonder on 06 Aug 2020
Principles for deliberative processes in health technology assessment
4 August 2020 - Deliberative processes are a well-established part of health technology assessment programs in a number of high- and ...
Posted by Michael Wonder on 21 Jul 2020
Pharma execs say FDA will not lower standards for coronavirus vaccine
21 July 2020 - Drug company executives sought to reassure House Democrats that the federal government is not lowering its ...
Posted by Michael Wonder on 16 Apr 2020
Bayer's chloroquine donation to U.S. raises concern about FDA standards in pandemic
16 April 2020 - On March 21, two days after President Donald Trump first touted chloroquine drugs as a “game ...
Posted by Michael Wonder on 30 Jan 2020
NICE publishes updated principles
30 January 2020 - NICE has today, 30 January 2020, published a simple guide to the way we develop our guidance ...
Posted by Michael Wonder on 13 May 2019
Two words to help Ned Sharpless revolutionise clinical trials: data standards
13 May 2019 - In the classic 1967 film “The Graduate,” young Benjamin Braddock was given one word of advice ...
Posted by Michael Wonder on 15 Feb 2019
Italy proposes the WHO set international standards for drug pricing transparency
14 February 2019 - As more countries seek to control their health care spending, the Italian government is asking the ...
Posted by Michael Wonder on 29 Jan 2019
Identifying the need for good practices in health technology assessment-summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA
26 January 2019 - The systematic use of evidence to inform healthcare decisions, particularly health technology assessment, has gained increased recognition. ...
Posted by Michael Wonder on 23 Jan 2019
Physicians’ perspectives on FDA approval standards and off-label drug marketing
22 January 2019 - Recently, two fundamental aspects of the US FDA’s pharmaceutical market oversight have become controversial. ...